We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Emergent Biosolutions Inc
17 own
11 watching
Current Price
$13.25
$-0.85
(-6.03%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
735.38M
52-Week High
47.71
52-Week Low
10.61
Average Volume
0.52M
Dividend Yield
--
P/E Ratio
7.8326
Market Capitalization735.38M52-Week High47.7152-Week Low10.61Average Volume0.52MDividend Yield--P/E Ratio7.8326What does the Emergent Biosolutions Inc do?
Emergent BioSolutions Inc. focuses on the development, manufacture, and commercialization of medical countermeasures that address public health threats. Its products address public health threats primarily chemical, biological, radiological, nuclear, and explosive-related threats, as well as infectious diseases. The company's marketed products include BioThrax, an anthrax vaccine; Anthrasil, a polyclonal antibody for the treatment of inhalational anthrax; BAT (Botulism Antitoxin Heptavalent) for the treatment of botulinum disease; vaccinia immune globulin intravenous that addresses adverse events from smallpox vaccination; reactive skin decontamination lotion kit for the removal or neutralization of chemical warfare agents; and Trobigard, an auto-injector device designed for intramuscular self-injection of atropine sulfate and obidoxime chloride. Its investigational stage product candidates include NuThrax, a next generation anthrax vaccine; UV-4B for dengue and influenza infections; GC-072 for Burkholderia pseudomallei; FLU-IG (NP025), a human polyclonal antibody therapeutic being developed to treat seasonal influenza; ZIKA-IG (NP024), a human polyclonal antibody therapeutic being developed as a prophylaxis for Zika infections; and FILOV (NP026), an equine polyclonal antibody therapeutic being developed to treat Ebola infections. In addition, the company provides contract manufacturing services to third-party customers. Emergent BioSolutions, Inc. was founded in 1998 and is headquartered in Gaithersburg, Maryland.
Read More
How much money does Emergent Biosolutions Inc make?
News & Events about Emergent Biosolutions Inc.
PR Newswire
1month ago
Thinking about buying stock in Spruce Biosciences, CytomX Therapeutics, Boxed, Mobile Global Esports, or Emergent Biosolutions? Thinking about buying stock in Spruce Biosciences, CytomX Therapeutics, Boxed, Mobile Global Esports, or Emergent Biosolutions? PR Newswire NEW YORK, Jan. 6, 2023 NEW...
The Mercury News: Health
1month ago
The FDA granted a pharmaceutical nonprofit priority review to make an inexpensive, over-the-counter nasal spray that reverses opioid overdoses.The FDA granted a pharmaceutical nonprofit priority review to make an inexpensive, over-the-counter nasal spray that reverses opioid overdoses, the ...
The Financial Express
7 months ago
Although it's possible that the virus could evolve with several mutations each year, experts don't expect that the mutations will emerge very frequently.
The World Health Organization might not have declared monkeypox an emergency yet but health experts around the world are vigilantes. A study has ...
Globe Newswire
7 months ago
GAITHERSBURG, Md., June 24, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that the U.S. Food and Drug Administration (FDA) accepted for review the Biologics License Application (BLA) for AV7909 (Anthrax Vaccine Adsorbed, Adjuvanted). AV7909 is the companys new ...
Frequently Asked Questions
Frequently Asked Questions
What is Emergent Biosolutions Inc share price today?
Can Indians buy Emergent Biosolutions Inc shares?
How can I buy Emergent Biosolutions Inc shares from India?
Can Fractional shares of Emergent Biosolutions Inc be purchased?
What are the documents required to start investing in Emergent Biosolutions Inc stocks?
What is today’s traded volume of Emergent Biosolutions Inc?
What is today’s market capitalisation of Emergent Biosolutions Inc?
What is the 52-Week High and Low Range of Emergent Biosolutions Inc?
What percentage is Emergent Biosolutions Inc down from its 52-Week High?
What percentage is Emergent Biosolutions Inc up from its 52-Week Low?
Current Price
$13.25
$-0.85
(-6.03%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.